← Leaderboards
Guido Ferrari
Duke University
$29,050,364
Attributed
$42,181,384
Total exposure
23
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,181,384 · 23
By mechanism
UM1$21,986,953 · 1
P01$7,995,986 · 3
R01$3,520,665 · 1
U19$3,466,129 · 2
T32$2,783,125 · 1
R56$1,177,733 · 2
Top collaborators
- Nathan M Thielman7 shared
- Wilton B Williams4 shared
- Erica Andersen-Nissen2 shared
- Clive Maurice Gray2 shared
- Kwasi Torpey2 shared
- Margaret E Ackerman1 shared
- Amy Lynn Corneli1 shared
- Nwora Lance Okeke1 shared
Most similar at Duke University
Same institution · by research overlap
- Justin Joseph Pollara$7,100,830
- Edward F Patz$1,534,306
- Jamie D. Roitman$551,984
- Rochelle D Schwartz-Bloom$533,700
- Richard Hodel$533,700
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionHiv-1Research PersonnelResponseVaccinesCollaborationsAcquired Immunodeficiency SyndromeBaseVaccine TrialHiv InfectionsProgramsReportingNeutralizing AntibodyImmune ResponseScientistTrainingEpidemicPathogenAfrica South Of The SaharaAfricanAfricaFutureSymposiumAntibody Response
Grant awards (61)
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens$4,630,856
UM1 · FY2025 · AI
Linking Antibody Cooperativity and Effector Cell Engagement$1,095,210
P01 · FY2025 · AI · contact PI
Interdisciplinary Research Training Program in AIDS$575,737
T32 · FY2025 · AI
Advanced Immuno-Technology Core$270,567
P30 · FY2025 · AI · contact PI
Infectious Diseases in Africa (IDA) Training Symposium for Next Gen Scientists$50,000
R13 · FY2025 · AI · contact PI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens$5,733,658
UM1 · FY2024 · AI
Linking Antibody Cooperativity and Effector Cell Engagement$826,439
P01 · FY2024 · AI · contact PI
Interdisciplinary Research Training Program in AIDS$362,695
T32 · FY2024 · AI
The 18th INTEREST Conference$65,000
R13 · FY2024 · AI · contact PI
Infectious Diseases in Africa (IDA) Training Symposium for Next Gen Scientists$50,000
R13 · FY2024 · AI · contact PI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens$5,902,563
UM1 · FY2023 · AI
Linking Antibody Cooperativity and Effector Cell Engagement$958,020
P01 · FY2023 · AI · contact PI
Interdisciplinary Research Training Program in AIDS$496,660
T32 · FY2023 · AI
17th INTERNATIONAL CONFERENCE ON HIV TREATMENT, PATHOGENESIS, AND PREVENTION RESEARCH (INTEREST)$65,000
R13 · FY2023 · AI · contact PI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens$5,719,876
UM1 · FY2022 · AI
Linking Antibody Cooperativity and Effector Cell Engagement$957,431
P01 · FY2022 · AI · contact PI
New analytic approaches and endpoints in human HIV vaccine correlate studies$792,039
R56 · FY2022 · AI
Interdisciplinary Research Training Program in AIDS$404,635
T32 · FY2022 · AI
Interdisciplinary Research Training Program in AIDS$72,981
T32 · FY2022 · AI
2022 International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST)$70,000
R13 · FY2022 · AI · contact PI
Infectious Diseases in Africa: Correlates of Protection, Lessons from Vaccines and Natural Infection Studies$1
R13 · FY2022 · AI · contact PI
Linking Antibody Cooperativity and Effector Cell Engagement$751,989
P01 · FY2021 · AI · contact PI
Interdisciplinary Research Training Program in AIDS$424,255
T32 · FY2021 · AI
Infectious Diseases in Africa: Correlates of Protection, Lessons from Vaccines and Natural Infection Studies$25,000
R13 · FY2021 · AI · contact PI
Antibody Cooperation mediated by Fc-gamma Receptor (FcyR)-bearing cells$726,844
P01 · FY2020 · AI · contact PI
Interdisciplinary Research Training Program in AIDS$446,162
T32 · FY2020 · AI
14th International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST)$45,000
R13 · FY2020 · AI · contact PI
Infectious Diseases in Africa: Correlates of Protection, Lessons from Vaccines and Natural Infection Studies$25,000
R13 · FY2020 · AI · contact PI
Antibody Cooperation mediated by Fc-gamma Receptor (FcyR)-bearing cells$767,328
P01 · FY2019 · AI · contact PI
Humoral Responses$491,673
U19 · FY2019 · AI · contact PI
13th International Conference on HIV Treatment, Pathogenesis, and Prevention Research (Interest)$65,000
R13 · FY2019 · AI · contact PI
Infectious Diseases in Africa: Immune Escape and HIV Vaccines$53,045
R13 · FY2019 · AI · contact PI
Humoral Responses$689,748
U19 · FY2018 · AI · contact PI
Antibody Cooperation mediated by Fc-gamma Receptor (FcyR)-bearing cells$678,871
P01 · FY2018 · AI · contact PI
Infectious Diseases in Africa: Immune Escape and HIV Vaccines$51,500
R13 · FY2018 · AI · contact PI
2018 INTEREST Conference$45,000
R13 · FY2018 · AI · contact PI
Humoral Responses$898,908
U19 · FY2017 · AI · contact PI
Antibody Cooperation mediated by Fc-gamma Receptor (FcyR)-bearing cells$672,168
P01 · FY2017 · AI · contact PI
2017 INTEREST Conference$70,000
R13 · FY2017 · AI · contact PI
Infectious Diseases in Africa: Immune Escape and HIV Vaccines$48,401
R13 · FY2017 · AI · contact PI
Humoral Responses$851,094
U19 · FY2016 · AI · contact PI
Antibody Cooperation mediated by Fc-gamma Receptor (FcyR)-bearing cells$561,686
P01 · FY2016 · AI · contact PI
10th INTEREST Workshop on HIV$70,000
R13 · FY2016 · AI · contact PI
Humoral Responses$534,706
U19 · FY2015 · AI · contact PI
2013 Infectious Diseases in Africa: Measurement of Immune Responses$46,824
R13 · FY2015 · AI · contact PI
2013 Infectious Diseases in Africa: Measurement of Immune Responses$25,000
R13 · FY2014 · AI · contact PI
2013 Infectious Diseases in Africa: Measurement of Immune Responses$25,000
R13 · FY2013 · AI · contact PI
2009 Infectious Diseases in Africa: Measurement of Immune Responses$1
R13 · FY2011 · AI · contact PI
Poly-functional analyses of vaccine-induced T cell responses$415,464
R01 · FY2010 · AI · contact PI
2009 Infectious Diseases in Africa: Measurement of Immune Responses$29,660
R13 · FY2010 · AI · contact PI
Poly-functional analyses of vaccine-induced T cell responses$557,436
R01 · FY2009 · AI · contact PI
2009 Infectious Diseases in Africa: Measurement of Immune Responses$36,994
R13 · FY2009 · AI · contact PI
Poly-functional analyses of vaccine-induced T cell responses$395,565
R01 · FY2008 · AI · contact PI
Poly-functional analyses of vaccine-induced T cell responses$391,485
R01 · FY2007 · AI · contact PI
Infectious Diseases in Africa: Measurement of Immune Responses$18,800
R13 · FY2007 · AI · contact PI
Poly-functional analyses of vaccine-induced T cell responses$409,365
R01 · FY2006 · AI · contact PI
Poly-Functional Analysis/HIV-Vaccine T cell responses$385,694
R56 · FY2005 · AI
HIV Vaccine Induced CTL: Qualitative/Functional Analyses$346,500
R01 · FY2004 · AI
HIV Vaccine Induced CTL: Qualitative/Functional Analyses$346,500
R01 · FY2003 · AI
HIV Vaccine Induced CTL: Qualitative/Functional Analyses$346,500
R01 · FY2002 · AI
HIV Vaccine Induced CTL: Qualitative/Functional Analyses$311,850
R01 · FY2001 · AI